COc1cc2c(-c3ccc4[nH]ccc4c3)c(-c3ccc(C#N)cc3)oc(=O)c2cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?